Comparison - ADCT - NYSE

Weiss Ratings	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Fair
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Beta	1.63

Price History	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-24.07%
30-Day Total Return	-26.35%
60-Day Total Return	-36.60%
90-Day Total Return	-37.88%
Year to Date Total Return	-38.50%
1-Year Total Return	-72.23%
2-Year Total Return	-40.00%
3-Year Total Return	-91.79%
5-Year Total Return	--
52-Week High % Change	-75.28%
52-Week Low % Change	3.91%

Price	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$5.38
52-Week Low Price	$1.28
52-Week Low Price (Date)	Mar 31, 2025
52-Week High Price (Date)	Apr 08, 2024

Valuation	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Market Cap	131.78M
Enterprise Value	324.01M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-1.66
Earnings Per Share Growth	-43.56%
Price/Earnings To Growth	--
Price/Sales (TTM)	1.98
Price/Book (Q)	-0.65
Enterprise Value/Revenue (TTM)	4.57
Price	$1.23
Enterprise Value/EBITDA (TTM)	-2.51
Enterprise Value/EBIT	-2.48
Market Cap Category	Micro Cap

Dividends and Shares	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	105.40M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Phone Number	41 21 653 02 00
Address	--
Website	www.adctherapeutics.com
Country	Switzerland
Year Founded	2011

Profitability	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-184.44%
Profit Margin	-222.82%

Management Effectiveness	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-24.13%
Return on Equity	--

Income Statement	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	70.84M
Total Revenue (TTM)	70.84M
Revenue Per Share	$0.67
Gross Profit (TTM)	-69.18M
EBITDA (TTM)	-129.32M
EBIT (TTM)	-130.65M
Net Income (TTM)	-157.85M
Net Income Avl. to Common (TTM)	-157.85M
Total Revenue Growth (Q YOY)	0.71%
Earnings Growth (Q YOY)	63.86%
EPS Diluted (TTM)	-1.66
EPS Diluted Growth (Q YOY)	71.79%

Balance Sheet	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	250.87M
Cash Per Share (Q)	$2.38
Total Current Assets (Q)	307.39M
Total Preferred Equity (Q)	--
Total Equity (Q)	-202.64M
Current Ratio (Q)	3.820
Book Value Per Share (Q)	-$2.05
Total Assets (Q)	321.98M
Total Current Liabilities (Q)	80.47M
Total Debt (Q)	443.09M
Total Liabilities (Q)	524.62M
Total Common Equity (Q)	-202.64M

Cash Flow	ADCT - NYSE	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	-867.00K
Cash from Financing (TTM)	97.05M
Net Change in Cash (TTM)	-27.73M
Levered Free Cash Flow (TTM)	-87.38M
Cash from Operations (TTM)	-123.84M